PRE

Prenetics Global Limited - Class A Ordinary Share (PRE)

About Prenetics Global Limited - Class A Ordinary Share (PRE)

Prenetics Global Limited is a health sciences company, which engages in the provision of early detection, prevention, and treatment of cancer. The firm offers products and services under the brands of CircleDNA, Insighta, ACT Genomics, IM8, and Europa. IM8, a health and wellness brand which focuses on consumer health products. Europa, a U.S. sports distribution company. Insighta, a venture which focuses on the development of early cancer detection technologies. It also focuses on its CircleDNA and ACT Genomics business units. The CircleDNA business unit uses next-generation sequencing (NGS) technology for consumer deoxyribonucleic acid (DNA) test. The ACT Genomics business unit is involved in genomic profiling of solid tumors. It has a presence in the United States. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.

Details

Daily high
$5.31
Daily low
$5.10
Price at open
$5.13
52 Week High
$6.99
52 Week Low
$3.09
Market cap
62.7M
Dividend yield
0.00%
Volume
11,534
Avg. volume
9,390
P/E ratio
-1.29

Prenetics Global Limited - Class A Ordinary Share News

Details

Daily high
$5.31
Daily low
$5.10
Price at open
$5.13
52 Week High
$6.99
52 Week Low
$3.09
Market cap
62.7M
Dividend yield
0.00%
Volume
11,534
Avg. volume
9,390
P/E ratio
-1.29